Latest California Healthline Stories
Amgen Plows Ahead With Costly, Highly Toxic Cancer Dosing Despite FDA Challenge
The FDA told Amgen to test whether a quarter-dose of its lung cancer drug worked as well as the amount recommended on the product label. It did and with fewer side effects. But Amgen is sticking to the higher dose — which earns it an additional $180,000 a year per patient.
City-Country Mortality Gap Widens Amid Persistent Holes in Rural Health Care Access
People in their prime working years living in rural America are 43% more likely to die of natural causes, like diseases, than their urban counterparts, a disparity that grew rapidly in recent decades, according to a new federal report.
Overdosing on Chemo: A Common Gene Test Could Save Hundreds of Lives Each Year
The FDA and some oncologists have resisted efforts to require a quick, cheap gene test that could prevent thousands of deaths from a bad reaction to a common cancer drug.
Una prueba genética podría salvar la vida de cientos de pacientes en quimioterapia
Estos tipos de quimioterapia comunes son difíciles de tolerar en general, pero para los pacientes que tienen deficiencia de una enzima que metaboliza la droga, puede ser una tortura o causar la muerte.
California’s Expanded Health Coverage for Immigrants Collides With Medicaid Reviews
A state policy to extend Medi-Cal to qualified Californians without legal residency is running up against a federal requirement to resume eligibility checks. The redetermination process is causing many Latinos, who make up a majority of Medi-Cal beneficiaries, to be disenrolled.
Operating in the Red: Half of Rural Hospitals Lose Money, as Many Cut Services
A recent report finds half of America’s rural hospitals are losing money, and many are struggling to stay open. Researchers and advocates worry the hospitals’ financial spiral will have immediate and long-term health effects on their communities.
Toxic Gas That Sterilizes Medical Devices Prompts Safety Rule Update
The Environmental Protection Agency is tightening regulation of ethylene oxide, a carcinogenic gas used to sterilize medical devices. The agency is trying to balance the interests of the health care industry supply chain with those of communities where the gas creates airborne health risks.
Early Detection May Help Kentucky Tamp Down Its Lung Cancer Crisis
After a decade of work, a Kentucky program launched to diagnose lung cancer earlier is beginning to change the prognosis for residents by catching tumors when they’re more treatable.
Patients See First Savings From Biden’s Drug Price Push, as Pharma Lines Up Its Lawyers
A restructuring of the Medicare drug benefit has wiped out big drug bills for people who need expensive medicines. But the legal battle over drug negotiations means uncertainty over long-term savings.
FDA Move to Ban Hair Relaxer Chemical Called Too Little, Too Late
The FDA’s recent notice that it would move to ban formaldehyde in hair-straightening products comes more than a decade after researchers raised alarms about health risks. Scientists say a ban would still leave many dangerous chemicals in hair straighteners.